111 related articles for article (PubMed ID: 8252775)
1. A case of malignant haemangioendothelioma treated with recombinant interleukin-2.
Ansai S; Goto K; Aoki T; Hozumi Y; Aso K
Clin Exp Dermatol; 1993 Sep; 18(5):470-5. PubMed ID: 8252775
[TBL] [Abstract][Full Text] [Related]
2. [A dramatic effect of continuous intra-arterial injected recombinant interleukin-2 immunotherapy on malignant hemangioendothelioma].
Takano M; Suzuki Y; Asai T; Masuzawa M; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1991 Jun; 101(7):719-25. PubMed ID: 1942580
[TBL] [Abstract][Full Text] [Related]
3. [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2].
Fujioka A; Sezai Y
Nihon Hifuka Gakkai Zasshi; 1991 Aug; 101(9):959-63. PubMed ID: 1942594
[TBL] [Abstract][Full Text] [Related]
4. A case of malignant haemangioendothelioma showing response to interleukin 2 therapy.
Inadomi T; Fujioka A; Suzuki H
Br J Dermatol; 1992 Oct; 127(4):442-3. PubMed ID: 1419766
[No Abstract] [Full Text] [Related]
5. Malignant hemangioendothelioma.
Ihda H; Tokura Y; Fushimi M; Yokote R; Hashizume H; Shirahama S; Iwatsuki K; Murakami K; Takigawa M
Int J Dermatol; 1995 Nov; 34(11):811-6. PubMed ID: 8543420
[TBL] [Abstract][Full Text] [Related]
6. [Successful immunotherapy of malignant hemangioendothelioma using recombinant interleukin-2].
Masuzawa M; Higashi K; Nishioka K; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1988 Mar; 98(3):367-9. PubMed ID: 3261813
[No Abstract] [Full Text] [Related]
7. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.
Ohguri T; Imada H; Nomoto S; Yahara K; Hisaoka M; Hashimoto H; Tokura Y; Nakamura K; Shioyama Y; Honda H; Terashima H; Moroi Y; Furue M; Korogi Y
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1446-53. PubMed ID: 15817349
[TBL] [Abstract][Full Text] [Related]
8. [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2].
Fujioka A; Sugitani M; Suzuki Z; Tokita J; Yorimitsu K; Sezai Y
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1958-61. PubMed ID: 1877838
[TBL] [Abstract][Full Text] [Related]
9. Adhesion molecule expression and leucocyte trafficking following immunotherapy with recombinant interleukin-2.
Miles DW; Happerfield LC; Bobrow LG; Rubens RD
Histopathology; 1996 Apr; 28(4):301-8. PubMed ID: 8732338
[TBL] [Abstract][Full Text] [Related]
10. [A case of Stewart-Treves syndrome--treatment with recombinant interleukin 2 and a review of Japanese literature].
Nabeya R; Kobayashi M; Fujita M; Yorifuji K; Eguchi N; Okamoto S
Nihon Hifuka Gakkai Zasshi; 1990 Sep; 100(10):1029-39. PubMed ID: 2266596
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
12. Malignant angioendothelioma--effect of immunotherapy with Corynebacterium parvum.
Tan SG; Cotterill JA; Roberts MM; Cunliffe WJ
Acta Derm Venereol; 1978; 58(6):551-3. PubMed ID: 83086
[No Abstract] [Full Text] [Related]
13. Cutaneous malignant hemangioendothelioma: clinical and histopathological observations of nine patients and a review of the literature.
Bhutto AM; Uehara K; Takamiyagi A; Hagiwara K; Nonaka S
J Dermatol; 1995 Apr; 22(4):253-61. PubMed ID: 7608382
[TBL] [Abstract][Full Text] [Related]
14. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
[TBL] [Abstract][Full Text] [Related]
15. [Malignant hemangioendothelioma of the head in the elderly. Ultrastructural and immunohistological study].
Kanitakis J; Bendelac A; Chouvet B; Thivolet J
Ann Dermatol Venereol; 1985; 112(5):441-51. PubMed ID: 3898968
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of recombinant human interleukin-2 on the growth of murine hemangioendothelioma D14 in nude mice: occurrence of large granular cells in the tumor.
Sakura Y; Houkan T; Ootsu K; Shino A
Jpn J Cancer Res; 1991 Aug; 82(8):950-7. PubMed ID: 1910031
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistology of tumor tissue in local administration of recombinant interleukin-2 in head and neck cancer].
Saito T; Kawaguti T; Yoda J; Kimura T; Tabata T
Nihon Jibiinkoka Gakkai Kaiho; 1989 Aug; 92(8):1271-6. PubMed ID: 2685216
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of malignant angioendothelioma possibly succeeded in treatments].
Kashima M; Saito K
Nihon Hifuka Gakkai Zasshi; 1986 Oct; 96(11):1123-32. PubMed ID: 3807011
[No Abstract] [Full Text] [Related]
19. Haemangioendothelioma of the skin with adverse response to steroids--report of a case.
Sweeney EC; O'Leary AD; Blaney PJ
Ir J Med Sci; 1986 Jul; 155(7):234-7. PubMed ID: 3744749
[No Abstract] [Full Text] [Related]
20. Angiosarcoma of the scalp treated with OK-432 and rIL-2.
Miura H; Inui S; Sakai H; Hasebe N; Itami S; Yoshikawa K
Int J Dermatol; 2002 May; 41(5):286-8. PubMed ID: 12100706
[No Abstract] [Full Text] [Related]
[Next] [New Search]
